In the previous article, we listed a series of provisions which, if passed by the House of Representatives and signed by the president, would become law. Below are CMS regulatory actions that create flexibilities for MA and Part D plans have to waive certain requirements to help prevent the spread of COVID-19:

• waiving cost-sharing for COVID-19 tests
• waiving cost-sharing for COVID-19 treatments in doctors' offices or emergency rooms and services delivered via telehealth
• removing prior-authorization requirements
• waiving prescription refill limits
• relaxing restrictions on home or mail delivery of prescription drugs
• expanding access to certain telehealth services

These waivers break down barriers to beneficiaries accessing care and allow plans to work with pharmacies and providers to treat patients without burdensome requirements limiting their options during this outbreak. For more information, click here.

Here is a good article on telehealth.